WST vs. XRAY
Compare and contrast key facts about West Pharmaceutical Services, Inc. (WST) and DENTSPLY SIRONA Inc. (XRAY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WST or XRAY.
Key characteristics
| WST | XRAY | |
|---|---|---|
| YTD Return | 4.24% | -21.47% |
| 1Y Return | 1.58% | -30.91% |
| 3Y Return (Ann) | 3.43% | -24.98% |
| 5Y Return (Ann) | 25.35% | -11.79% |
| 10Y Return (Ann) | 24.53% | -4.12% |
| Sharpe Ratio | 0.00 | -1.21 |
| Daily Std Dev | 29.82% | 26.18% |
| Max Drawdown | -55.52% | -60.57% |
| Current Drawdown | -21.75% | -58.12% |
Fundamentals
| WST | XRAY | |
|---|---|---|
| Market Cap | $26.72B | $5.87B |
| EPS | $7.59 | -$0.62 |
| PEG Ratio | 6.72 | 1.53 |
| Revenue (TTM) | $2.93B | $3.96B |
| Gross Profit (TTM) | $1.14B | $2.13B |
| EBITDA (TTM) | $809.60M | $632.00M |
Correlation
The correlation between WST and XRAY is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
WST vs. XRAY - Performance Comparison
In the year-to-date period, WST achieves a 4.24% return, which is significantly higher than XRAY's -21.47% return. Over the past 10 years, WST has outperformed XRAY with an annualized return of 24.53%, while XRAY has yielded a comparatively lower -4.12% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
WST vs. XRAY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and DENTSPLY SIRONA Inc. (XRAY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
WST vs. XRAY - Dividend Comparison
WST's dividend yield for the trailing twelve months is around 0.22%, less than XRAY's 2.09% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WST West Pharmaceutical Services, Inc. | 0.22% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% | 0.78% |
XRAY DENTSPLY SIRONA Inc. | 2.09% | 1.57% | 1.57% | 0.77% | 0.76% | 0.66% | 0.94% | 0.53% | 0.54% | 0.48% | 0.50% | 0.52% |
Drawdowns
WST vs. XRAY - Drawdown Comparison
The maximum WST drawdown since its inception was -55.52%, smaller than the maximum XRAY drawdown of -60.57%. Use the drawdown chart below to compare losses from any high point for WST and XRAY. For additional features, visit the drawdowns tool.
Volatility
WST vs. XRAY - Volatility Comparison
West Pharmaceutical Services, Inc. (WST) has a higher volatility of 7.83% compared to DENTSPLY SIRONA Inc. (XRAY) at 7.38%. This indicates that WST's price experiences larger fluctuations and is considered to be riskier than XRAY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
WST vs. XRAY - Financials Comparison
This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and DENTSPLY SIRONA Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities